IONS
Ionis Pharmaceuticals, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #649
- Final score
- 43.60
- Years on list
- 6
↗ Climbed 270 since 2020
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- IONS· Ionis Pharmaceuticals, Inc.
- VRTX· Vertex Pharmaceuticals Incorporated
- HALO· Halozyme Therapeutics, Inc.
Figure 01 · Side-by-side summary
The headline numbers
VRTX
Vertex Pharmaceuticals IncorporatedPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #618
- Final score
- 45.58
- Years on list
- 6
↘ Down 130 since 2020
HALO
Halozyme Therapeutics, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #665
- Final score
- 42.98
- Years on list
- 1
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | IONS | VRTX | HALO |
|---|---|---|---|
| Climate Change | 47.7 | 57.2 | 45.8 |
| Employee Relations | 35.5 | 48.3 | 39.5 |
| Environment | 48.4 | 40.0 | 72.3 |
| Stakeholders & Society | 58.4 | 42.4 | 24.3 |
| Human Rights | 16.8 | 34.2 | 15.6 |
| Governance | 44.6 | 39.2 | 39.3 |
| Performance Rating | 57.7 | 50.6 | 54.1 |